2 Marvelous Marijuana Stocks in the Making

Alcanna Inc. (TSX:CLIQ) and The Supreme Cannabis Company, Inc. (TSXV:FIRE) might be unheralded but both are absolutely marvelous marijuana stocks in the making.

Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

The controversies involving the big cannabis players shouldn’t distract you. Otherwise, you’ll lose sight of the smaller but marvelous marijuana stocks in the making. Alcanna (TSX:CLIQ) and Supreme Cannabis (TSXV:FIRE) are quietly making the right moves in the sidelines.

Both companies are gearing up to gain headway in Canada’s direct cannabis market that will be worth $11 billion in the next six years. You need to keep watch of these companies whose business models are dynamic and growth-oriented.

Transformed business

Alcanna is dominating the retail liquor business in Canada. The company posted a third straight quarter of steady market share gains. There was a 20.9% growth in sales and an 8.2% growth in same-store sales in the three and six months ended June 30, 2019 compared with the same period in 2018.

James Burns, Alcanna’s Vice Chairman, and CEO said the company is working to re-establish market foothold after losing it to competitors. Alcanna is competing but slowly adapting to the low gross margin environment. Selective margin enhancement will begin in the second half of 2019 when Alcanna regains market share.

The company has nine retail cannabis stores under the brand Nova Cannabis. The construction of other stores is ongoing, and the target is to have an additional 15 to 20 stores by year-end. Alcanna is also converting some of its liquor stores to retail cannabis stores.

Entry into the cannabis world would strengthen Alcanna’s balance sheet as it builds a solid foundation for long-term growth and value appreciation.

Underrated weed stock

Supreme Cannabis remains underrated. However, the company is taking deliberate steps to grow and build an active business and authentic brand.

The audited fourth-quarter results aren’t due until September 17, 2019, but Supreme Cannabis already gave investors a glimpse of what to expect. Revenue is expected to increase by 449% or nearly double versus Q4 2018 revenue.

Navdeep Dhaliwal, Supreme Cannabis’ CEO, is confident that the measured approach to capital deployment and brand-building will set the company apart. Revenue growth will continue throughout 2020.

One of Supreme Cannabis’ operating assets, 7ACRES, will scale production and introduce new and higher-margin products. The launching of 7ACRES premium oil pod for the PAX Era is coming son. Other significant operating assets and cannabis brands are Truverra, Blissco, Medigrow, and Super Heights.

Cambium Plant Sciences will handle the research and development for Supreme Cannabis. This R&D facility focuses on the development of the next generation of premium cannabis genetics and proprietary cultivation processes.

Supreme Cannabis is forecasting net revenue of $150 to $180 million in 2020. Also, this quarter, 7ACRES’ transition from a wholesale business to premium consumer brand will be complete.  Analysts see FIRE rising from $1.46 to $4.50 or an upside of 208% in the next twelve months.

Colossal gains in the future

You shouldn’t belittle Alcanna and Supreme Cannabis, however. Both companies are transitioning and growing and could well outperform the more significant but problematic cannabis producers.

If you’re after colossal gains in the cannabis sector, invest in Alcanna and Supreme while the stocks are affordable. These marvelous marijuana stocks in the making will command higher prices soon.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »